Article Versions Notes

Kalabay M, Szász Z, Láng O, Lajkó E, Pállinger É, Duró C, Jernei T, Csámpai A, Takács A, Kőhidai L. Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines. Pharmaceuticals. 2022; 15(3):314. https://doi.org/10.3390/ph15030314

Kalabay, Márton, Zsófia Szász, Orsolya Láng, Eszter Lajkó, Éva Pállinger, Cintia Duró, Tamás Jernei, Antal Csámpai, Angéla Takács, and László Kőhidai. 2022. "Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines" Pharmaceuticals 15, no. 3: 314. https://doi.org/10.3390/ph15030314

Kalabay, M., Szász, Z., Láng, O., Lajkó, E., Pállinger, É., Duró, C., Jernei, T., Csámpai, A., Takács, A., & Kőhidai, L. (2022). Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines. Pharmaceuticals, 15(3), 314. https://doi.org/10.3390/ph15030314